Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia

PLoS One. 2012;7(11):e48926. doi: 10.1371/journal.pone.0048926. Epub 2012 Nov 12.

Abstract

Objectives: The beneficial effects of cardiac resynchronization therapy (CRT) are thought to result from favorable left ventricular (LV) reverse remodeling, however CRT is only successful in about 70% of patients. Whether response to CRT is associated with a decrease in ventricular arrhythmias (VA) is still discussed controversially. Therefore, we investigated the incidence of VA in CRT responders in comparison with non-responders.

Methods: In this nonrandomized, two-center, observational study patients with moderate-to-severe heart failure, LV ejection fraction (LVEF) ≤35%, and QRS duration >120 ms undergoing CRT were included. After 6 months patients were classified as CRT responders or non-responders. Incidence of VA was compared between both groups by Kaplan-Meier analysis and Cox regression analysis. ROC analysis was performed to determine the aptitude of LVEF cut-off values to predict VA.

Results: In total 126 consecutive patients (64±11 years; 67%male) were included, 74 were classified as responders and 52 as non-responders. While the mean LVEF at baseline was comparable in both groups (25±7% vs. 24±8%; P = 0.4583) only the responder group showed an improvement of LVEF (36±6% vs. 24±7; p<0.0001) under CRT. In total in 56 patients VA were observed during a mean follow-up of 28±14 months, with CRT responders experiencing fewer VA than non-responders (35% vs. 58%, p<0.0061). Secondary preventive CRT implantation was associated with a higher likelihood of VA. As determined by ROC analysis an increase of LVEF by >7% was found to be a predictor of a significantly lower incidence of VA (AUC = 0.606).

Conclusions: Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / physiopathology*
  • Arrhythmias, Cardiac / therapy*
  • Cardiac Resynchronization Therapy*
  • Female
  • Follow-Up Studies
  • Heart Failure / complications
  • Heart Failure / therapy
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • ROC Curve
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Function, Left*
  • Ventricular Remodeling

Grants and funding

CM received support as a fellow of the European Heart Rhythm Association for the 1-year fellowship (advanced program) in interventional electrophysiology (mentor: Prof Helmut Purerfellner). CM is also the recipient of a research grant from the Hans-und-Gertie-Fischer Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.